Furthermore, immune response dysfunction is associated with overactivation of the JAK‐STAT signal, and thus, newly discovered JAK inhibitors have been demonstrated to be successful in treating autoimmune conditions like UC [35] and rheumatoid arthritis [36]. Here, SOAT1 is linked to rheumatoid arthritis.